Evidence map›Paper›PMID 38104323›Full record

ArticleACS infectious diseases2024

Fosfomycin Uptake in

Martina Bianchi, Mathias Winterhalter, Theresa Anisja Harbig, Daniel Hörömpöli, Ishan Ghai, Kay Nieselt, Heike Brötz-Oesterhelt, Christoph Mayer, Marina Borisova-Mayer

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. The Metabolic State ofACS infectious diseases · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Antibiotic resistance inFrontiers in microbiology · 2026
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Martina BianchiDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), University of Tübingen, 72076 Tübingen, Germany.ORCID 0009-0001-9660-6060
Mathias WinterhalterDepartment of Life Sciences and Chemistry, Constructor University, 28759 Bremen, Germany.
Theresa Anisja HarbigInstitute for Bioinformatics and Medical Informatics, University of Tübingen, 72076 Tübingen, Germany.
Daniel HörömpöliDepartment of Microbial Bioactive Compounds, IMIT, University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-5236-8443
Ishan GhaiDepartment of Life Sciences and Chemistry, Constructor University, 28759 Bremen, Germany.ORCID 0000-0003-3713-403X
Kay NieseltInstitute for Bioinformatics and Medical Informatics, University of Tübingen, 72076 Tübingen, Germany.
Heike Brötz-OesterheltDepartment of Microbial Bioactive Compounds, IMIT, University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0001-9364-1832
Christoph MayerDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0003-4731-4851
Marina Borisova-MayerDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0001-6557-8581
University of Tübingen · DEUniversity of Bremen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibiotic fosfomycin (FOS) is widely recognized for the treatment of lower urinary tract infections with

Indexed as

Escherichia coli ProteinsFosfomycinBiological TransportEscherichia coliPorinsEscherichia coli ProteinsFosfomycinPorinsEscherichia colifosfomycinLamBOmpCOmpFouter-membrane porin

Identifiers

PMID38104323
PMCPMC10789261
OpenAlexW4389856210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.